Do Recent Epidemiologic Observations Impact Who and How We Should Screen for CRC?

被引:0
|
作者
Ethan Bortniker
Joseph C. Anderson
机构
[1] Department of Veterans Affairs Medical Center,Division of Gastroenterology and Hepatology
[2] The Geisel School of Medicine at Dartmouth,undefined
[3] University of Connecticut School of Medicine,undefined
来源
关键词
Colorectal neoplasia; Risk factors; Models; Colonoscopy;
D O I
暂无
中图分类号
学科分类号
摘要
Colorectal cancer (CRC) screening is recommended to begin at age 50 for those patients with no significant family history of CRC. However, even within this group of average-risk patients, there is data to suggest that there may be variation in CRC risk. These observations suggest that perhaps CRC screening should be tailored to target those patients at higher risk for earlier or more invasive screening as compared to those individuals at lower risk. The strategy of how to identify those higher-risk patients may not be straightforward. One method might be to use single risk factors such as smoking or elevated BMI as has been suggested in the recent American College of Gastroenterology CRC screening guidelines. Another paradigm involves the use of models which incorporate several risk factors to stratify patients by risk. This article will highlight recent large studies that examine recognized CRC risk factors as well as review recently developed CRC risk models. There will also be a discussion of the application of these factors and models in an effort to make CRC screening more efficient.
引用
收藏
页码:781 / 794
页数:13
相关论文
共 50 条
  • [31] REVIEW: How Should We Screen for Colorectal Cancer?
    Solomon Singh
    Jamie S. Barkin
    Digestive Diseases and Sciences, 2002, 47 : 1982 - 1983
  • [32] How should we screen for sleep apnea in pregnancy?
    Ouyang, David
    Stewart, Noreen
    Adams, Marci
    Facco, Francesca
    Grobman, William
    Kick, Ashley
    Zee, Phyllis
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 : S225 - S226
  • [33] When and how should we screen for hereditary hemochromatosis?
    Chalès, G
    Guggenbuhl, P
    JOINT BONE SPINE, 2003, 70 (04) : 263 - 270
  • [34] Acute myeloid leukemia in the elderly: do we know who should be treated and how?
    Nazha, Aziz
    Ravandi, Farhad
    LEUKEMIA & LYMPHOMA, 2014, 55 (05) : 979 - 987
  • [35] How should we screen for gastric cancer in Iran
    Khedmat, H
    Amini, M
    Yari, F
    Proceedings of the 6th International Gastric Cancer Congress, 2005, : 597 - 600
  • [36] How frequently should we screen for oral cancer?
    Nagao, T
    Warnakulasuriya, S
    JOURNAL OF DENTAL RESEARCH, 2000, 79 (05) : 1174 - 1174
  • [37] Hemoptysis: How far should we workup and who should we follow?
    Chan, King-Pui Florence
    Lam, David Chi-Leung
    Ip, Mary Sau-Man
    Tam, Terence Chi-Chun
    RESPIROLOGY, 2023, 28 : 189 - 189
  • [38] Bioanalytical method validation: How much should we do and how should we document?
    Gérard Hopfgartner
    Analytical and Bioanalytical Chemistry, 2020, 412 : 531 - 532
  • [39] Bioanalytical method validation: How much should we do and how should we document?
    Hopfgartner, Gerard
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2020, 412 (03) : 531 - 532
  • [40] Pancreatic cancer: can we screen? How should we stage?
    Parikh A.A.
    Lowy A.M.
    Current Gastroenterology Reports, 1999, 1 (2) : 166 - 174